Record Production of Crystalline Iodine
Iofina produced a record 743 metric tons of crystalline iodine in FY2025 (produced), and sold 780 metric tons (including shipments delayed from FY2024). Production has grown from ~500 t in 2022 to 743 t in 2025 (~+49%), and management expects a run-rate near 1,000 tpa once the Permian plant and IO#11 are fully ramped.
Strong Revenue Growth
Group revenue reached $66.5 million in FY2025, up 22% year-over-year, driven by higher volumes and stronger realized iodine pricing.
Higher Realized Iodine Pricing
Average realized 100% iodine selling price increased to $74.02/kg in FY2025 from $68.60/kg in FY2024, an increase of ~8%, supporting gross profit expansion.
Record EBITDA and Profitability Metrics
Reported EBITDA of $11.8 million in FY2025 (record for the group). Cost of sales across plants increased only ~2% year-over-year, helping maintain margins despite expansion.
Successful Plant Builds and Attractive Project Economics
IO#11 Came online July 2025 on time and on budget (~$5.3M capex), producing ~100 tpa with an expected ~3-year payback. New Permian Basin plant (Q3 2026) is on time and on budget (~$8–9M capex, modeled to produce 150–220 tpa) and provides step-change scale with favorable unit economics.
Improved Cash Position and Manageable Debt
Cash balance of $11.7M and net cash of $5.2M at FY2025 (up from $2.9M prior), with bank debt of $6.5M (includes $4M drawn for IO#11). Management expects to retire remaining 2020 loan by end of next year and to use existing banking relationships to fund growth prudently.
Clear Growth Roadmap to 2,000 tpa
Company presented a targeted plan to move from ~1,000 tpa to 2,000 tpa within 3–4 years by accelerating plant builds (larger Permian-style plants and multiple sites in pipeline), with forecasted capex and an intention to use some debt alongside cash generation.
Diversified End-Market Exposure and Sales Geography
Iofina sells roughly 50% to North America and 50% to the rest of the world (largest component Asia), and chemical derivatives account for ~30% of iodine revenue, supporting market diversification as production scales.